TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
The latest update is out from Pharmaxis Ltd ( (AU:SNT) ).
Syntara Limited has updated its corporate governance framework to align with the ASX Governance Principles, ensuring robust management and oversight structures. The framework includes a board charter, director checks, written agreements with executives, and a direct accountability structure for the company secretary, enhancing transparency and governance integrity.
The most recent analyst rating on (AU:SNT) stock is a Buy with a A$0.06 price target. To see the full list of analyst forecasts on Pharmaxis Ltd stock, see the AU:SNT Stock Forecast page.
More about Pharmaxis Ltd
Syntara Limited is an Australian company listed on the Australian Securities Exchange (ASX). The company has developed a corporate governance framework consistent with the ASX Governance Principles, focusing on management oversight, board structure, ethical culture, corporate report integrity, timely disclosure, security holder rights, risk management, and fair remuneration.
Average Trading Volume: 7,328,631
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$42.32M
For a thorough assessment of SNT stock, go to TipRanks’ Stock Analysis page.